Table 3.
Interaction:a | KD (nM) | ΔGb (kcal mol−1) | ΔH (kcal mol−1) | −TΔSc (kcal mol−1) | nd |
---|---|---|---|---|---|
B3P3 RNA Titrated into Splicing-Factor Complexes | |||||
SF11–255-U2AF65R12U, site 1 | 2 ± 1 | −12.1 ± 0.1 | −60.1 ± 0.1 | 47.9 ± 0.1 | 0.8 ± 0.1 |
SF11–255-U2AF65R12U, site 2 | 500 ± 10 | −8.7 ± 0.1 | −65.3 ± 0.1 | 56.6 ± 0.1 | 0.3 ± 0.1 |
Phospho-SF11–255-U2AF65R12U, site 1 | 7 ± 5 | −11.5 ± 0.1 | −60.4 ± 0.1 | 48.9 ± 0.1 | 0.8 ± 0.1 |
Phospho-SF11–255-U2AF65R12U, site 2 | 600 ± 80 | −8.7 ± 0.1 | −65.3 ± 0.1 | 57.6 ± 0.1 | 0.4 ± 0.1 |
SF1pa-U2AF65R12U | 85 ± 1 | −9.8 ± 0.1 | −67.5 ± 0.1 | 57.7 ± 0.1 | 0.9 ± 0.1 |
SF1mut-U2AF65R12U | 82 ± 1 | −9.8 ± 0.1 | −76.7 ± 0.1 | 66.9 ± 0.1 | 0.9 ± 0.1 |
SF1mut-U2AF65R12Ue | 104 ± 7 | −9.7 ± 0.2 | −68.4 ± 0.2 | 58.6 ± 0.2 | 1.0 ± 0.1 |
Splicing-Factor Complexes Titrated into B3P3 RNAf | |||||
SF11–255-U2AF65R12U, site 1 (reverse) | 160 ± 80 | −9.5 ± 0.1 | −22.3 ± 0.1 | 12.8 ± 0.1 | 0.6 ± 0.1 |
SF11–255-U2AF65R12U, site 2 (reverse) | 7 ± 1 | −11.3 ± 0.1 | −53.2 ± 0.1 | 42.0 ± 0.1 | 0.9 ± 0.2 |
Phospho-SF11–255-U2AF65R12U, site 2 (reverse) | 115 ± 5 | −9.8 ± 0.1 | −81.1 ± 4.9 | 71.4 ± 4.9 | 0.5 ± 0.1 |
Phospho-SF11–255-U2AF65R12U, site 1 (reverse) | 18 ± 3 | −10.8 ± 0.1 | −36.2 ± 4.5 | 25.5 ± 4.7 | 0.7 ± 0.2 |
Values are expressed as the mean ± SD of at least two independent titrations.
ΔG values were calculated using the equation ΔG = −RT ln (KA) where T=303 K
−TΔS values were calculated using the equation −TΔS = ΔG − ΔH.
Fits are “ligand-in-cell” such that “n” is the apparent stoichiometry of protein/RNA.
Dialyzed into 100 mM NaCl and 25 mM sodium phosphate buffer (pH 7.4). Macromolecules for other experiments in this table were in 100 mM NaCl, 25 mM HEPES (pH 7.4).
Apparent stoichiometry of protein/RNA (n).